![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Medtronic Receives FDA Approval of Spinal Cord Stimulator
Medtronic Receives FDA Approval of Spinal Cord Stimulator
![](https://www.fdanews.com/ext/resources/test/Device_Images3/Medtronic.gif?t=1433878552&width=430)
September 20, 2017
Medtronic received FDA approval of the Intellis platform for the management of certain types of chronic pain.
The device is placed under a patient's skin to deliver mild electrical impulses through a lead implanted in the epidural space to block pain signals from going to the brain.
The device tracks and records patient activity 24/7 and is managed on the Samsung Galaxy Tab S2 tablet interface, enabling physicians to monitor progress and make modifications to suit their patients' therapy needs.
Upcoming Events
-
21Oct